Aim: This study evaluated two methods, namely high performance liquid chromatography with fluorescence detection (HPLC-FLD) and Vibrio harveyi BB170 bioassay, for autoinducer-2 (AI-2) quantification in marine samples. Using both methods, the study also investigated the stability of AI-2 in varying pH, temperature and media, as well as quantified the amount of AI-2 signals in marine samples. Methods and Results: HPLC-FLD method showed a higher level of reproducibility and precision compared to V. harveyi BB170 bioassay. Alkaline pH (>8) and high temperature (>37°C) increased the instability of AI-2. The AI-2 concentrations in seawater were low, c. 3Á2-27Á6 pmol l À1 , whereas 8-week-old marine biofilm grew on an 18Á8 cm 2 substratum accumulated c. 0Á207 nmol of AI-2. Conclusion: Both methods have pros and cons for AI-2 quantification in marine samples. Regardless, both methods reported a ubiquitous presence of AI-2 in both planktonic and biomass fractions of seawater, as well as in marine biofilm. Significance and Impact of the Study: In this study, AI-2 signals were for the first time enumerated in marine samples to reveal the ubiquitous presence of AI-2 in this environment. The findings suggest a possible role of AI-2 in biofilm formation in marine environment, and the contribution of AI-2 in biofilm-associated problems such as biofouling and biocorrosion.
Introduction
Bacteria utilize quorum sensing (QS) system to communicate with each other and to coordinate certain behaviours in response of cell density. QS is mediated by small signal molecules named autoinducers. Autoinducers mainly comprise three groups: autoinducer-1 (AI-1), autoinducer-2 (AI-2) and autoinducer peptide (AIP). Among these three identified QS signals, AI-2 is considered as a universal signal that can mediate intra-and interspecies communication among bacteria. This is because all AI-2 signals found to date (Chen et al. 2002; Miller et al. 2004) come from the same precursor named 4,5-Dihydroxy-2,3-pentanedione (DPD). The ubiquitous biosynthesis pathway of DPD by LuxS enzyme is widely distributed in various Gram-positive and Gram-negative bacteria. Furthermore, DPD signal can spontaneously rearrange into different interconvertible DPD derivatives ( Fig. S1 ) and mediate intra or interspecies QS in different bacteria (Xavier and Bassler 2005; Gonzalez Barrios et al. 2006) . DPD and the DPD isomers with AI-2 activity are collectively referred to as AI-2 (Xavier et al. 2007) . The feature of AI-2 is in contrast to the intraspecies AI-1 (i.e. N-acyl homoserine lactone, AHL) and AIP which are secreted by Gram-negative bacteria and Gram-positive bacteria respectively.
Through bioinformatics analysis, LuxS/AI-2 is identified to be widely distributed in the marine environment (Bodor et al. 2008; Doberva et al. 2015) , implying that AI-2 may be produced by marine micro-organisms and can play a potential role in microbial-associated problems (e.g. biofilm formation) prevalent in the seawater application systems. For example, Jahid et al. (2015) found correlation between AI-2 secretion and biofilm formation by Aeromonas hydrophila in saline media. In a separate study, the application of an AI-2 inhibitor was found to reduce biofilm formation in marine strain Halomonas pacifica (Liaqat et al. 2014 ) and mitigate membrane biofouling in seawater desalination RO system (Katebian et al. 2016) . Collectively, these studies imply the possibility of AI-2 related biofilm formation in marine environment. However, most of these studies provide qualitative description of the role of AI-2 in marine biofilm formation, and do not quantify the threshold concentration of AI-2 signal molecules associated with these marine biofilms.
The lack of quantitative measurements was probably related to the difficulties associated with AI-2 quantification. The current methods for AI-2 quantification are classified into biological-based and chemical-based methods. One of the biological methods is to utilize the marine bacterial reporter Vibrio harveyi BB170 (Bassler et al. 1994 ) as a biosensor. V. harveyi BB170 was engineered to maintain its AI-2 regulation pathway and to produce bioluminescence in response to AI-2 signal. Past studies showed that the accuracy and reproducibility of this bioassay can be easily affected by the assay conditions (e.g. borate concentration, pH and other growth conditions etc.) and by unknown interference from the culture supernatant (DeKeersmaecker and Vanderleyden 2003; Turovskiy and Chikindas 2006; Vilchez et al. 2007) .
Alternatively, AI-2 can also be determined by analytical instruments. So far, there is no existing protocol developed for directive quantification of AI-2 using analytical method (e.g. HPLC, GC, HPLC-MS/MS etc.). This is because that DPD is inherently unstable and dynamically changes to its various isomeric forms which complicates direct monitoring. Instead, derivatization helps to convert AI-2 signal pools into a more stable and/or fluorescent form that can be identified or quantified by analytical method such as HPLC-FLD (Song et al. 2014) . This analytical method was earlier shown to accurately determine AI-2 in biological samples. However, to date, the method has not been applied to quantify AI-2 in biological samples retrieved from marine environments.
In this study, we aim to evaluate the use of both V. harveyi BB170 bioassay method and chemical HPLC-FLD method to quantify AI-2 in marine water and biofilm samples. The stability of AI-2 was first investigated in simulated marine conditions, including high salinity, and with varying temperature and pH. We then demonstrate the use and compared the suitability of the methods to quantify AI-2 signals in marine samples.
Materials and methods

AI-2 detection by HPLC-FLD method
AI-2 was detected by determining DPD as surrogate. A standard curve of DPD was prepared by diluting the commercial DPD solutions (3Á9 mmol l À1 DPD in 1 mmol l À1 KHSO 4, pH 1Á5; Omm Scientific Inc., Dallas, TX, USA) with deionized water to different concentrations ranging from 0Á001 to 200 lmol l À1 . DPD concentration was determined in triplicate for each concentration. Derivatization and HPLC analysis were performed as described previously (Song et al. 2014) . Briefly, 400 ll DPD sample and 400 ll Dan solution (0Á2 g l À1 2,3-diaminonaphthalene in 0Á1 mol l À1 HCl)
were added to an autosampler vial and mixed for 2 min. This step maintained the final pH of reaction sample at acidic condition (<pH 2), which will stabilize AI-2 signals and prevent false positive result caused by carbohydrates in the sample (Song et al. 2014) . The vial was then incubated in a water bath at 90°C for 40 min to allow the derivatization reaction to proceed (Fig. S2 ). The short derivatization time was chosen based on findings from Song et al. (2014) and to ensure that AI-2 does not degrade due to unnecessarily long derivatization duration. After cooling down to room temperature, 20 ll of the derivation product was analysed with a Waters Breeze TM 2 HPLC system equipped with a Binary HPLC pump (Waters 1525), an autosampler (Waters 2707), a phenomenex Luna C18 (2) Column (5 lm particle size, 4Á6 9 250 mm) and a scanning fluorescence detector (Waters 474) at excitation and emission wavelength of 271 and 503 nm respectively. The separation was carried out at room temperature with a mobile phase flow rate of 0Á8 ml min À1 using the following gradient elution profile: t = 0 min, 70% solution A (HPLC grade water with 0Á1% formic acid), 30% solution B (HPLC grade acetonitrile); t = 4 min, 70% solution A, 30% solution B; t = 12 min, 35% solution A, 65% solution B; t = 20 min, 35% solution A, 65% solution B; t = 24 min, 70% solution A, 30% solution B; t = 27 min, 70% solution A, 30% solution B. The derivatization product was detected at a retention time of approximately 9Á4 min.
AI-2 detection by V. harveyi BB170 bioassay
Commercial DPD solution was diluted to various concentrations ranging from 0Á001 to 200 lmol l À1 , and the DPD was determined in triplicate for each concentration. V. harveyi BB170 bioassay was carried out using protocols detailed in a previous study (Bassler et al. 1997 ) with some modifications. Briefly, the V. harveyi BB170 strain (luxN::tn5Kan) was grown at 30°C in autoinducer bioassay (AB) medium (Bassler et al. 1994 ) for 15 h. The cell culture was then diluted 1 : 5000 into fresh AB medium. Subsequently, 180 ll of the diluted culture was added with 20 ll of sample to be tested for AI-2 concentrations. All samples to be tested, including controls and replicates, were aliquoted into 96-well plates. The plates were incubated at 30°C, shaking at 100 rev min À1 for 4 h and the luminescence response of the biosensor was monitored using Infinite 200 pro microplate reader (Tecan, M€ annedorf, Switzerland). The AI-2 activity registered by the bioassay method was expressed as the fold induction of the reporter strain in the presence of sample over background control (AB medium).
Evaluation of HPLC-FLD and bioassay methods
The HPLC-FLD and bioassay methods were evaluated and compared based on linearity, the limit of detection (LOD), the limit of quantification (LOQ), the determination of reproducibility, specificity, and intra-and interday precision. Three independent experiments were carried out. LOD and LOQ of HPLC-FLD method were calculated using the equations 1 and 2 respectively (Shrivastava and Gupta 2011):
where SD denotes the standard deviation of y-intercepts of regression lines and S denotes the slope of the calibration curve. For bioassay method, LOD was defined as the concentration that shows the fold change in bioluminescence as 1Á5 and LOQ was defined as the concentration that shows minimum fold change in the standard calibration curve.
To test the reproducibility of the two methods, a standard DPD sample (1 lmol l À1 ) was measured by HPLC-FLD method and bioassay for six times. The relative standard deviation (RSD) of the measured DPD concentrations was calculated using Eqn 3:
where STD denotes the standard deviation, and M denotes the mean value. for bioassay) in a single day for three times. The interday precision of the two methods was evaluated by determining known concentrations of DPD (1 and 10 lmol l
À1
for HPLC method, or 0Á2 and 0Á8 lmol l À1 for bioassay) spiked into deionized water for three times on five consecutive days. All the results obtained were evaluated against known spiked concentrations. Statistical analysis was performed using MINITAB 17.2 and Origin Pro 2015.
DPD determination in various media at control conditions
DPD stock solutions were mixed with 1 ml of the six reagents (i.e. H 2 O, PBS, Tris-HCl, HSAS, LB and HSAS-CP) to obtain a final concentration of 100 lmol l À1 .
Samples were determined immediately by both HPLC-FLD method and bioassay for the DPD concentrations.
DPD stability in various media at elevated temperatures
The stability of DPD at elevated temperatures was investigated by incubating 100 lmol l À1 DPD in 1 ml of the six above-mentioned media at 37 or 50°C, 200 rev min À1 for 18 h. After incubation, DPD samples were determined by HPLC-FLD method or bioassay. HPLC-FLD or bioassay result of 100 lmol l À1 DPD in deionized water at 22°C and with no incubation was defined as the 100% baseline positive control, and used for the normalization of all test results.
Stability of DPD at various pH values
To test the effect of pH on the stability of DPD at both 37 and 50°C, DPD was mixed in HSAS solution to 100 lmol l À1 and adjusted to pH 2, 4, 6, 7, 8, 10 with 1 mol l À1 HCl or NaOH. The DPD solutions were incubated at 37 or 50°C and the DPD concentrations determined by the HPLC-FLD method and BB170 bioassay at fixed time intervals of 0, 6, 12, 18, 24, 30, 36 and 40 h. HPLC-FLD and BB170 bioassay result of 100 lmol l
À1
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Quantification of AI-2 concentration in seawater and marine biofilm samples
Three samples from marine source were tested for AI-2 determination. First, Red Sea water sample S1 was collected from a piped connection at Water Desalination and Reuse Center, KAUST. Another two seawater samples named S2 and S3 came from two different sampling points in a pilot scale seawater cooling tower (PCT) system located at KAUST's central Utilities Plant (Fig. S3 ). Sample S2 was obtained from a seawater equalization tank, dosed with antiscaling chemicals (NO.3DT135; Nalco, Naperville, IL, USA). Sample S3 was obtained from the cooling tower system at the point where heat transfer and recirculation occur. Sampling point for S3 was maintained with 0Á2 mg l À1 chlorine. Sample S3 was also determined to contain higher salinity and maintained at higher temperature than S1 and S2. All three samples were sampled twice at different times (Table S1 ). Seawater samples were prepared for AI-2 determination in the following manner. Samples were first filtered through 0Á2-lm polyvinylidene fluoride (PVDF) membrane to retain biomass on the membranes. Subsequently, all membrane samples with biomass were aseptically cut into pieces prior to suspension in deionized H 2 O respectively. Suspensions were then ultrasonicated in Q500 sonicator (Qsonica, Newtown, CT) at amplitude 25%, and at an on-off pulsing interval of 2 s for 3 min. Sonicated samples were centrifuged at 8000 g for 10 min. Supernatant of each sample was filtered through 0Á2-lm cellulose acetate membrane filter and subjected to freezedrying in Alpha 1-2 LD plus (Martin Christ, Osterode am Harz, Germany). Subsequently, the lyophilized content was denoted as the biomass portion associated with the respective seawater sample (Table S1 ).
Filtrates obtained after the 0Á2-lm PVDF membrane filtration were subject to Oasis HLB solid phase extraction (SPE) cartridge (Waters, Milford, MA) for AI-2 concentration. The SPE procedure was performed by first conditioning the cartridge with 5 ml methanol and 5 ml water. Then, 1 l filtrate was passed through the cartridge. After drying with gas for 30 min, the cartridge was rinsed with 5 ml water and eluted with 10 ml methanol with 0Á1% formic acid. The eluted solvents were evaporated with nitrogen, and the residue was denoted as the filtrate portion associated with the respective seawater sample (Table S1 ).
Recovery efficiency with Oasis HLB cartridge was evaluated by concentrating 35 ml of 1 and 0Á1 lmol l À1 DPD in deionized water to 3Á5 ml. Recovery efficiency was calculated using the Eqn 4:
where DPD S and DPD 0 stand for the concentration of DPD after and before SPE treatment. In addition to seawater samples, marine biofilm samples were grown in a drip flow reactor system for approximately 8 and 10 weeks, and quantified for their AI-2 concentrations. The biofilm was grown on 10 pieces of polyethersulfone ultrafiltration membranes with dimensions of 25 9 75 mm (GE Osmonics, Boston, MA) that were placed in the 10-channel drip flow reactors (Biosurface Technologies, Bozeman, MT). Fresh seawater collected from Red Sea was pumped into the drip flow reactors at a flow rate of 0Á3 l h À1 , and dripped onto the membrane surface at a 10°angle. In the 8th and 10th week of biofilm growth, four pieces of membranes with attached biofilm were collected aseptically and suspended in 200 ll deionized water. After sonication for 3 min, the mixture was centrifuged. The supernatant, after filtration by a 0Á2-lm filter, was freeze-dried for AI-2 quantification. All the treated samples were determined for AI-2 concentration by both HPLC-FLD method and bioassay. Interference peaks were observed near the 9Á4 min retention time on HPLC for environmental samples. To facilitate a better identification of DPD-associated peaks, high performance liquid chromatography-tandem mass spectrometry (HPLC-MS/MS) was conducted to verify those peaks.
Results
Evaluation of HPLC-FLD method
HPLC-FLD-based method showed linearity over a broad range of DPD concentrations (Fig. 1a) . Two linear regression curves (H1 and H2) covering different ranges of concentrations (0Á01-0Á4 and 0Á4-100 lmol l À1 ) were defined (Table 1 ). The two linear fitted lines showed high correlation of determination (R 2 = 0Á998). The LOD and LOQ of HPLC-FLD method based on H2 were 11 and 35 nmol l À1 respectively. The peak area in H1 curve showed higher RSD than that observed in H2 curve, with a maximum RSD of 88Á6%. 
Evaluation of BB170 bioassay method
The response of V. haryeyi BB170 to DPD aqueous solution was linear over a concentration range of 0Á08-1 lmol l À1 (Fig. 1b) . A single linear regression curve B1
covering the entire DPD concentration range of 0Á08-1 lmol l
À1
was defined for DPD concentration determination at high correlation of determination (R 2 = 0Á997) ( Table 1) . The LOD and LOQ of the bioassay were 40 and 80 nmol l À1 , respectively, and were at least three times higher than that for HPLC-FLD method (Fig. 1b) . The RSD of the B1 curve in bioassay was also up to three times higher than that of H2 curve in HPLC-FLD method. At higher concentration range of 1-10 lmol l À1 , the bioassay method did not show linear relationship although the magnitude of fold induction can reflect the relative DPD level among samples (Fig. 1b) 
DPD determination in various media at control conditions
One hundred lmol l À1 DPD dissolved in deionized water, PBS, Tris-HCl, HSAS, LB and HSAS-CP at 22°C was determined by the HPLC-FLD and the bioassay methods. The concentration of DPD calculated by the HPLC-FLD method was unaffected by the matrix (one-way ANOVA, P > 0Á05) (Fig. 2a) . For the AI-2 bioassay method, TrisHCl and PBS did not have great impact on DPD determination (P > 0Á05), while HSAS, LB and HSAS-CP caused great interference to DPD determination (P < 0Á05). Relative bioluminescence of DPD in HSAS decreased to 59%, and DPD in LB and HSAS-CP resulted in only 24 and 26% of bioluminescence compared with DPD in deionized water (Fig. 2b) . Dilution of the test solutions improved the accuracy of bioassay method (Fig. 2c ), but diluted LB medium and HSAS-CP resulted in a significantly higher relative bioluminescence compared to the other diluted media (one-way ANOVA, P < 0Á05).
Stability of DPD in various media at elevated temperatures
When determined by the HPLC-FLD method, DPD concentration remained stable in deionized water and HSAS after 18 h incubation at 37 and 50°C (Fig. 2a) . DPD concentrations in all other solutions decreased to varying extent as temperature increased from 22°C to 37 or 50°C. Temperature caused a significant effect on DPD stability when determined by the HPLC-FLD method (one-way ANOVA, P < 0Á05). Based on the HPLC-FLD method, DPD concentration dropped to 73 and 47% after 18 h of incubation in HSAS-CP and LB media, respectively, at 37°C compared to 22°C. The stability of DPD was 3Á3 and 8Á1 times higher in Tris-HCl (pH 7Á4) buffer than in PBS buffer (pH 6Á7) at 37 and 50°C. However, the same trend was not observed when DPD was determined based on bioassay method, and the DPD concentrations determined in different media at 37°C were not significantly different (one-way ANOVA, P > 0Á05) (Fig. 2b) . The same trend as that observed by HPLC-FLD method was only reproduced by bioassay method when samples were diluted prior to detection (Fig. 2c) .
The stability of DPD in HSAS at various pH values
The stability of DPD over time at various pH values and high temperatures was determined using the HPLC-FLD method. At time = 0 h, DPD concentration at pH from 2 to 8 was at 100-110%. However, the DPD concentration decreased to 77% when dissolved at pH 10. DPD was highly stable in acidic pH as 100% of DPD concentration was determined in pH range from 2 to 6 after 40 h of incubation at 37°C (Fig. 3a) , and more than 87% DPD concentration remained after 40 h of incubation at 50°C for the same pH range of 2-6 (Fig. 3b) . The DPD instability increased at neutral and alkaline pH over time. DPD was completely inactivated at pH 10 within 6 h incubation at 37 and 50°C. Similar observations were made using the bioassay method (Fig. 3c,d) , and it was observed that the decrease in DPD was more apparent at all tested pH ranges when measured by the bioassay method than when determined by the HPLC-FLD method. To exemplify, no bioluminescence representative of DPD was detected by bioassay method at pH 10 at time = 0 h. While DPD concentrations remained stable in acidic pH when quantified by HPLC-FLD method, the bioassay showed a decreased trend for DPD at acidic pH.
Determination AI-2 concentration in marine samples
Based on the HPLC-FLD method, AI-2 concentrations in the biomass portion of S1, S2 and S3 were 0Á4-0Á6, 5Á4-6Á3 and 4Á8-8Á7 pmol l À1 , respectively (Fig. 4a) , while AI-2 concentration in the biomass from S1, S2 and S3 were 0Á9-8Á0, 2Á8-79Á5 and 27Á4-29Á6 pmol l À1 ), respectively, after bioassay determination (Fig. 4b) . HPLC-FLD result reveals the free AI-2 concentrations in the bulk water phase (i.e. filtrate) were 2Á6-5Á0, 2Á4-3Á9 and 5Á1-18Á9 pmol l À1 for S1, S2 and S3 respectively (Fig. 4a ).
AI-2 bioassay of and filtrate phases of the S1, S2 and S3-2 were 5Á0-20Á8, 103Á3-129Á9 and 19Á3 pmol l À1 , except for S3-1 filtrate where no bioluminescence was detected (Fig. 4b) . Given that the recovery efficiencies of SPE cartridge for 1 lmol l À1 DPD solution and 0Á1 lmol l À1 DPD solution were only 19Á13 and 50Á31%, respectively, the actual concentration of AI-2 in filtrate samples could be higher than the detected amount. Four membranes with 8-week-old marine biofilm established on membrane surfaces in a DFR reactor were determined to have an average AI-2 amount of 0Á104 AE 0Á018 and 0Á236 AE 0Á081 nmol by the HPLC-FLD and the bioassay method respectively. As the biofilm grew to 10 weeks old, AI-2 amount increased to 0Á207 AE 0Á055 and 0Á242 AE 0Á014 nmol, respectively, by these two methods (Fig. 5) . by BB170 bioassay. HPLC-FLD and bioassay result of 100 lmol l À1 DPD in HSAS (pH 2) at 22°C, time = 0 h was defined as 100% respectively (• pH = 2; 9 pH = 4; □ pH = 6; M pH = 7; ✳ pH = 8; ▲ pH = 10).
Discussion
Determining AI-2 concentration in the marine habitats is essential to facilitate our understanding on the possible roles of AI-2-related QS activity in marine bacterial community. However, to date, limited studies are available to provide an indication on the range of concentrations of AI-2 in seawater environment or marine community habitat. To address these knowledge gaps, two AI-2 determination methods, namely the HPLC-FLD and the V. harveyi BB170 bioassay, were first assessed and compared for their efficacy in detecting AI-2 in conditions that simulate the marine environments. Both methods were then used to evaluate the stability of AI-2 at high temperatures, over a wide range of pH and in various media, including those of high salinity. It was observed that both AI-2 determination methods showed pros and cons (Table 2) . Specifically, the HPLC-FLD method had a broader linear range in AI-2 determination than the (Song et al. 2014) . In addition, the HPLC-FLD method was able to generate comparatively more accurate and reproducible results, as evidenced from the lower RSD compared with the bioassay method. Other chemical methods using gas chromatography-mass spectrometry (GC-MS) (Thiel et al. 2009) or HPLC-MS/MS method (Xu et al. 2016 ) also showed good reproducibility for AI-2 quantification. The bioassay method, in contrast, exhibited low accuracy and reproducibility, particularly when AI-2 concentrations were in the high range and would require predilution of samples. At high concentrations of DPD (e.g. >1 lmol l À1 ), the standard curve of the bioassay shows a sigmoid trend (Fig. 1b) , which suggest cooperative binding of the luciferase. An earlier study observed that the increase in luminescence by Vibrio fisheri with AHL concentrations also followed a pattern that fit into a cooperative binding model (Perez and Hagen 2010) , and that luminescence signals saturate at high concentrations of AHL. This deviation from the linearity of quantification would mean that bioassay method is not suitable for determining samples with high AI-2 concentrations. Furthermore, unlike the HPLC-FLD method, the standard curve for the bioassay method has to be created for each new determination trial to alleviate problems associated with the low reproducibility of this method. The bioassay method was also more affected by pH and salinity associated with the samples, reiterating findings obtained from earlier studies that suggested bioassay methods to be detrimentally impacted by the assay conditions. The quantification of 100 lmol l À1 DPD in H 2 O, PBS, Tris-HCl, HSAS, LB, HSAS-CP by the HPLC-FLD method was unaffected by the type of matrix (Fig. 2a) . However, the relative DPD concentrations in HSAS, LB and HSAS-CP were calculated to decrease to 58, 24 and 26%, respectively, in comparison with the concentration of DPD in H 2 O (i.e. control) when the bioassay method was used (Fig. 2b) . Instead, DPD samples had to be diluted 100-fold prior to bioassay method to show similar trend with the ones determined by HPLC-FLD (Fig. 2c) . This suggested that samples diluted to the linearity range for BB170 assay can be beneficial to DPD quantification; and that sample dilution minimizes the interference effects and improves the overall reproducibility of the bioassay method (Taga and Xavier 2011) . However, there are two exceptions where the concentrations of DPD diluted in LB and HSAS-CP medium increased to 142 and 140% compared with the control. The false positive result was probably caused by DPD analogue formation by carbohydrate present in the complex matrices (Thiel et al. 2009 ).
In general, the stability of DPD at elevated temperatures of 37 and 50°C depends on the media. According to the HPLC-FLD method, 100 lmol l À1 DPD in H 2 O and HSAS was stable after 18 h incubation under 37 and 50°C. However, when in PBS, Tris-HCl, LB and HSAS-CP, 18 h of incubation of the samples at 37°C resulted in 26, 88, 47 and 73% of DPD concentrations, respectively, compared to the control. When incubated at 50°C, the instability of DPD was further aggravated in these four media. These findings suggested an interactive effect between the solution matrix and temperature, although the exact mechanisms behind accelerated degradation of DPD under these factors remain unknown. DPD exhibited stability in HSAS at acidic pH (pH 2-6) but as pH increased, the DPD concentration decreased with time. Previously, Globisch et al. showed DPD appeared in different isomers in aqueous solution and the composition of the isomers was closely dependent on pH. The adjustment of pH from alkaline to acidic range was further demonstrated to recover DPD activity (Globisch et al. 2012) . However, our study showed irreversible inactivation of DPD in alkaline pH. Nevertheless, seawater usually has a relatively high boric acid content, and binding borate to DPD would lead to the formation of relative stable cyclic borate AI-2 molecule, thus increasing the life time of DPD in the marine environment. However, AI-2 concentration in the marine environment has not been reported extensively and remains to be elucidated.
To address this knowledge gap, the methods evaluated in this study were used to detect and quantify AI-2 concentrations in various types of seawater samples. To make sure that the AI-2 concentrations falls within the detection range of both methods, the marine samples were concentrated by lyophilization for the biomass portion or SPE for the filtrate portion. SPE was applied to concentrate AI-2 in filtrate as it can remove the excess salt in the seawater samples. Our study showed recovery efficiency of SPE varied across the different batches of samples. This was probably due to the high polarity and water solubility of AI-2 signals (Thiel et al. 2009; Pereira et al. 2013) . The combination of these two factors would mean that a good interaction between the signals and SPE column cannot be easily established, and that AI-2 signals may be unintentionally eluted away when performing column washing steps to get rid of accumulated salts from seawater samples. Regardless, AI-2 was detected from both biomass and filtrate of seawater samples using HPLC-FLD method (Fig. 4a) . This suggested that AI-2 signal molecules exist intracellularly in marine bacterial community and are subsequently excreted to the environment. AI-2 concentration measured in all samples collected from the marine environment was in pmol l À1 level (ranges from 3Á2-27Á6 pmol l À1 based on the HPLC-FLD result), which is lower from the AI-2 concentration detected in the pure strain cultures (e.g. 1Á95 lmol l À1 reported for V. harveyi and 0Á26 lmol l
À1
reported for Streptococcus mutans) (Thiel et al. 2009 ). It was previously reported that the minimum working concentration for AI-2 required to trigger biofilm formation of LuxS-deficient oral commensal bacteria was 0Á08 nmol l À1 (Rickard et al. 2006) . Hence, it is unlikely that the amount of AI-2 in seawater is able to trigger QS activity given the low concentration. However, when the planktonic cells adhere on surfaces and accumulate, the total AI-2 concentration would likely increase with time, and accelerate biofilm formation process. To exemplify, the total amount for AI-2 in 20 l planktonic phase of S1 sample was calculated to be 0Á008-0Á013 nmol. In contrast, the detected AI-2 amount in the 10th week biofilm was approximately 16 times higher (0Á207 nmol). This accumulation of AI-2 in bacteria was also observed by Xavier and Bassler (2003) in an earlier study, which noted that AI-2 accumulation was proportional to cell numbers, and that as long as the AI-2-producing cells grow, AI-2 will continue to be produced due to metabolic process. These AI-2 signals were observed to accumulate to threshold concentrations when associated with biofilm as young as 8 weeks old, suggesting an either consequential or causative effect imposed by AI-2 in biofilm formation. So far, the most widely studied AHL family was shown to play a main role in marine biofilm formation (Hmelo 2017) . Although not deeply explored, AI-2 with the interspecies feature may have greater impact on mixed bacteria community in a marine habitat. Further studies should aim to utilize these methods to detect and quantify AI-2 in a larger set of marine samples, and to provide a mechanistic understanding on the role of AI-2 in the marine environment. In summary, our study demonstrated the use of two methods, namely the HPLC-FLD and the BB170 bioassay methods to detect AI-2 concentrations in the marine environment. Specifically, the HPLC-FLD provides more reproducible and precise measurements than the bioassay method regardless of the media, pH and temperature. When further applied to detect for AI-2 signals in the planktonic and biomass phase of seawater as well as that associated with marine biofilm, both methods showed the ubiquitous presence of AI-2 signals in the marine environment. Figure S1 Possible isomers of 4,5-Dihydroxy-2,3-pentanedione (DPD) as illustrated by (Guo et al., 2015) . Figure S2 Derivatization reaction of DPD with 2,3-diaminonaphthalene illustrated by (Song et al. 2014) . Figure S3 Schematic of pilot scale cooling tower (PCT) system and two sampling points (marked with yellow stars) used for AI-2 determination in this study. Figure  was 
